<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) that transformed to Burkitt's <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL) </plain></SENT>
<SENT sid="1" pm="."><plain>The leukaemic blasts were negative for peroxidase staining, and expressed CD10, CD19, CD22, CD38, human leucocyte antigen (HLA)-DR and surface immunoglobulin (sIg) M, but neither sIgD nor sIgG were expressed </plain></SENT>
<SENT sid="2" pm="."><plain>Chromosomal study during the ALL phase showed t(8;22)(q24;q11) in addition to the karyotypes determined during the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> phase </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, overexpression of c-myc <z:chebi fb="2" ids="33699">mRNA</z:chebi> was confirmed in ALL blasts </plain></SENT>
<SENT sid="4" pm="."><plain>These findings indicate that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> transformed to Burkitt's ALL through multiple cytogenetic evolutions, the final event of which seems to be overexpression of the c-myc gene </plain></SENT>
</text></document>